比亞迪股份(01211.HK)擬分拆比亞迪半導體上市
格隆匯12月30日丨比亞迪股份(01211.HK)公吿,於2020年12月30日,公司董事會會議審議通過《關於擬籌劃控股子公司分拆上市的議案》,經審議,董事會同意公司控股子公司比亞迪半導體股份有限公司籌劃分拆上市事項,並授權公司及比亞迪半導體管理層啟動分拆比亞迪半導體上市的前期籌備工作,包括但不限於可行性方案的論證、組織編制上市方案、簽署籌劃過程中涉及的相關協議等上市相關事宜,並在制定分拆上市方案後將相關上市方案及與上市有關的其他事項分別提交公司董事會、股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.